FathomX
FathomX is a Singapore-based medical imaging AI spin-off from the National University of Singapore, founded in 2019, that develops AI-powered technology to assist healthcare providers in breast cancer detection and diagnosis.
- Company typePrivate
- Founded2019
- HeadquartersSingapore, Singapore
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
FathomX firmographics
Firmographics- Name
- FathomX
- Website
- https://fathomx.co
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- FathomX is a Singapore-based medical imaging AI spin-off from the National University of Singapore, founded in 2019, that develops AI-powered technology to assist healthcare providers in breast cancer detection and diagnosis.
- Ownership category
- akta.pro rank
FathomX industry classification
Industry- Product category
- Medical Imaging AI
- akta.pro primary industry
- Medical Imaging AI (HDAAAEAH)
- akta.pro secondary industries
- SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG), Mammography & Breast Imaging Systems (HLAHABAF)
Keywords
Where FathomX is headquartered
LocationHeadquarters
- HQ city
- Singapore
- HQ country
- Singapore
- HQ region
- Asia
Markets served
FathomX business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D
FathomX product offering
Product offeringCore offering
FathomX is an AI medical imaging company that develops artificial-intelligence-based software for breast cancer detection and diagnosis. As a spin-off from the National University of Singapore, the company applies AI to breast imaging analysis to help healthcare providers improve diagnostic accuracy and efficiency in mammography and related workflows.
Differentiator
Problem solved
Functional benefit
Products and services
- AI Breast Cancer Detection Software AI-powered software for breast cancer detection and diagnosis from medical imaging, intended for healthcare providers performing breast cancer screening and diagnosis.
Companies that use FathomX
Customer profileSegments1 record
Ideal customer profiles1 record
FathomX technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
FathomX partnerships and signals
Strategic signalScale indicators1 record
FathomX competitors and assessment
Company assessmentEmerging players
- Zebra Medical Vision (Nanox AI): Zebra Medical Vision, now part of Nanox, is a broad medical imaging AI vendor whose multi-modality strategy partially overlaps with FathomX's diagnostic AI positioning as an emerging peer.
- Qure.ai: Qure.ai is an emerging medical imaging AI vendor with FDA-cleared chest and head CT products that is expanding into adjacent imaging AI use cases, partially overlapping with FathomX's diagnostic AI positioning.
- DeepTek.ai: DeepTek is an India-based medical imaging AI company with deployments in APAC, representing a regional emerging peer with overlapping AI imaging technology but broader modality coverage.
Direct peers
- Volpara Health Technologies: Volpara is a publicly-listed breast imaging analytics company offering AI-driven mammography reporting, density assessment, and cancer risk prediction. It directly competes with FathomX in breast cancer AI for screening workflows.
- iCAD, Inc. iCAD develops AI-based computer-aided detection and breast density solutions for mammography, directly overlapping with FathomX's breast cancer detection and diagnosis use case.
- Therapixel: Therapixel is a French company specializing in AI-powered mammography reading (MammoScreen), making it a direct peer to FathomX in breast imaging AI diagnostics.
- Lunit: Lunit is a Korean medical AI company whose Lunit INSIGHT MMG product targets mammography AI, directly competing with FathomX in the same clinical workflow with regional APAC overlap.
Broad incumbents
- Hologic, Inc. Hologic is a major mammography equipment vendor (3D Dimensions) with an integrated AI portfolio (Genius AI). It competes with FathomX as an incumbent that bundles imaging AI into its hardware sales.
- DeepHealth (RadNet subsidiary): DeepHealth, a RadNet company, offers AI-driven mammography triage and diagnostic solutions (Saige-Dx). It is a broad incumbent providing integrated breast imaging AI in large-scale screening networks.
- Google Health (breast cancer AI): Google Health has published and deployed AI models for mammography screening in research and partnership settings, representing a well-resourced broad incumbent in the breast imaging AI category.
Market position
Customer concentration
FathomX social profiles
Digital presenceFathomX financial estimates
Financial estimateRevenue estimate
Valuation estimate
FathomX leadership team
Management profileNumber of profiles
Profiles6 records
FathomX funding detail
Funding detailFunding overview
Funding rounds6 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FathomX M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FathomX
What does FathomX do?
FathomX is an AI medical imaging company that develops artificial-intelligence-based software for breast cancer detection and diagnosis. As a spin-off from the National University of Singapore, the company applies AI to breast imaging analysis to help healthcare providers improve diagnostic accuracy and efficiency in mammography and related workflows.
Is FathomX a public or private company?
FathomX is a private company. It is classified as venture growth investor backed and is currently operating.
When was FathomX founded?
FathomX was founded in 2019. It employs 11 to 50 people.
Where is FathomX based?
FathomX is headquartered in Singapore, Singapore, in the Asia region.
Who are FathomX's main competitors?
Emerging players on record are Zebra Medical Vision (Nanox AI), Qure.ai and DeepTek.ai. Direct peers are Volpara Health Technologies, iCAD, Inc., Therapixel and Lunit. Broad incumbents are Hologic, Inc., DeepHealth (RadNet subsidiary) and Google Health (breast cancer AI).
Does FathomX have an API?
No public API is recorded for FathomX.
What industry is FathomX in?
FathomX's product category is Medical Imaging AI. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML).